Kapitalo Investimentos’s Exact Sciences EXAS Stock Holding History

Kapitalo Investimentos’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-64,428	Closed	-$6.54M	–	60
2025 Q4	$6.54M	Buy	+64,428	New	+$5.17M	1.25%	14
2023 Q4	–	Sell	-4,147	Closed	-$283K	–	594
2023 Q3	$283K	Buy	+4,147	New	+$352K	0.04%	205

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Kapitalo Investimentos's EXAS Position: Q1 2026 in Review

Kapitalo Investimentos sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 64,428 shares — an estimated $6.54M sold.

Kapitalo Investimentos first reported a position in EXAS in Q3 2023 and held it in 2 quarters. The position peaked at $6.54M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Kapitalo Investimentos reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Kapitalo Investimentos sold 64,428 Exact Sciences shares in Q1 2026, an estimated $6.54M.
Kapitalo Investimentos first reported a position in Exact Sciences in Q3 2023 and held it in 2 quarters.
Kapitalo Investimentos's Exact Sciences position peaked at $6.54M in Q4 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Kapitalo Investimentos's 13F filing for Q1 2026, filed 7 May 2026.